Bladder Cancer Expert Team

Chair

Mark S. Litwin, MD

Mark S. Litwin, MD

Urology| Urologic Oncology

Chair, Department of Urology. Professor of Urology, Health Policy & Management, and Nursing. He trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. He created and directs IMPACT, a state-funded program that provides free medical care statewide for low-income, uninsured men with prostate cancer. 

UCLA Faculty and Providers

Karim Chamie, MD

Karim Chamie, MD

Minimally Invasive Urology| Urology| Urologic Oncology

Associate Professor of Urology and Society of Urologic Oncology Fellowship Director. He attended Medical School at USC and completed Urological training at UC Davis. Dr. Chamie then completed a SUO certified fellowship in Urologic Oncology at UCLA. His primary research interests are health services research and clinical trials in bladder cancer. His clinical interests include all areas of urologic oncology, with a particular emphasis on bladder cancer and robotic surgery. More >

Arnold I. Chin, MD, PhD

Arnold I. Chin, MD, PhD

Minimally Invasive Urology| Urology| Urologic Oncology

Associate Professor of Urology and Medical Director, Urology-Westwood. Dr. Chin completed his M.D., Ph.D. and Urology residency training at UCLA. His clinical expertise includes urologic oncology and renal transplantation. He performs open, laparoscopic, and robotic-assisted surgeries for patients with all urologic malignancies including bladder, kidney, and prostate cancer. More >

Allan J. Pantuck, MD

Allan J. Pantuck, MD

Urology| Urologic Oncology

Professor of Urology and Vice Chair of Academic Affairs for Urology. Dr. Pantuck specializes in urologic cancers and has a long standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment. More >

Robert E. Reiter, MD

Robert E. Reiter, MD

Urology| Minimally Invasive Urology| Urologic Oncology

Professor of Urology, Professor of Molecular Biology, Chief of the Division of Urologic Oncology, Director of the Prostate Cancer Program, Bing Research Chair in Urology, Co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center. Dr. Reiter attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute. More >

Christopher S. Saigal, MD

Christopher S. Saigal, MD

Minimally Invasive Urology| Urology| Urologic Oncology

Professor and Executive Vice Chair of Urology. Clinical practice, UCLA Westwood Campus. He is also on the staff of the West Los Angeles Veterans Affairs Medical Center. Dr. Saigal has had a longstanding clinical interest in urologic cancers and the surgical treatment of benign prostatic hyperplasia. His research is focused on patient-centered decision support and quality of care for urologic conditions. More >